High materiality7/10
Xenon Pharmaceuticals price target lowered to $60 from $78 at Needham
Why it may matterVerify against the original reporting
bearish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
XENE received an analyst target update from Needham. Target: $60; Posted price: $57.35; Analyst: Needham; Price change since signal: -30.74
- Target: $60
- Posted price: $57.35
- Analyst: Needham
- Price change since signal: -30.74
Key facts
- 01
Target: $60
- 02
Posted price: $57.35
- 03
Analyst firm: Needham
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.